New Anti‐Angiogenic Therapy for Glioblastoma With the Anti‐Depressant Sertraline

ABSTRACT Background and Aims Anti‐angiogenic therapies prolong patient survival in some malignancies but not glioblastoma. We focused on the relationship between the differentiation of glioma stem like cells (GSCs) into tumor derived endothelial cells (TDECs) and, anti‐angiogenic therapy resistance....

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Nobushige Tsuboi, Yoshihiro Otani, Atsuhito Uneda, Joji Ishida, Yasuki Suruga, Yuji Matsumoto, Atsushi Fujimura, Kentaro Fujii, Hideki Matsui, Kazuhiko Kurozumi, Isao Date, Hiroyuki Michiue
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Wiley 2024-10-01
Rangatū:	Cancer Medicine
Ngā marau:	anti‐angiogenic therapy antidepressant sertraline drug repositioning glioblastoma tumor derived endothelial cells
Urunga tuihono:	https://doi.org/10.1002/cam4.70288
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!